Healthy volunteers needed to test medicine combo in Early-Stage study
NCT ID NCT07284173
First seen Jan 10, 2026 · Last updated May 05, 2026 · Updated 14 times
Summary
This early-stage study looks at how a new experimental medicine, PF-08049820, is processed by the body when taken alone and when taken with a common stomach acid drug called rabeprazole. About 18 healthy Chinese adults will take both combinations by mouth and provide blood samples. The goal is purely to gather information on drug levels and safety, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY ADULTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beijing Friendship Hospital Affiliate of Capital University
Beijing, Beijing Municipality, 100050, China
-
Beijing Friendship Hospital Affiliate of Capital University
Beijing, Beijing Municipality, 101100, China
Conditions
Explore the condition pages connected to this study.